These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30849700)

  • 41. Generation of HIV-1 potent and broad neutralizing antibodies by immunization with postfusion HR1/HR2 complex.
    Dawood R; Benjelloun F; Pin JJ; Kone A; Chanut B; Jospin F; Lucht F; Verrier B; Moog C; Genin C; Paul S
    AIDS; 2013 Mar; 27(5):717-30. PubMed ID: 23719346
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibody engineering and its therapeutic applications.
    Kandari D; Bhatnagar R
    Int Rev Immunol; 2023; 42(2):156-183. PubMed ID: 34355613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Engineered antibodies take center stage.
    Huston JS; George AJ
    Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tools of the trade: developing antibody-based detection capabilities for recombinant proteins.
    Dolan MC; Medrano G; McMickle A; Cramer CL
    Methods Mol Biol; 2012; 824():65-105. PubMed ID: 22160894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation of PrP-specific Polyclonal Antibody
    Yang XH; Wu YZ; Xiao K; Gao LP; Chen DD; Dong XP; Shi Q
    Biomed Environ Sci; 2020 Jul; 33(7):493-501. PubMed ID: 32807268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid generation of human recombinant monoclonal antibodies from antibody-secreting cells using ferrofluid-based technology.
    Strazza V; Rossi M; Avati A; Tiseo G; Falcone M; Cusi MG; Menichetti F; Ricciardi-Castagnoli P; Tinti C; Pileri P
    Front Immunol; 2024; 15():1341389. PubMed ID: 38698845
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Parallel immunizations of rabbits using the same antigen yield antibodies with similar, but not identical, epitopes.
    Hjelm B; Forsström B; Löfblom J; Rockberg J; Uhlén M
    PLoS One; 2012; 7(12):e45817. PubMed ID: 23284606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recombinant antibodies possessing novel effector functions.
    Love TW; Runge MS; Haber E; Quertermous T
    Methods Enzymol; 1989; 178():515-27. PubMed ID: 2513468
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapid generation of potent antibodies by autonomous hypermutation in yeast.
    Wellner A; McMahon C; Gilman MSA; Clements JR; Clark S; Nguyen KM; Ho MH; Hu VJ; Shin JE; Feldman J; Hauser BM; Caradonna TM; Wingler LM; Schmidt AG; Marks DS; Abraham J; Kruse AC; Liu CC
    Nat Chem Biol; 2021 Oct; 17(10):1057-1064. PubMed ID: 34168368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications.
    Ayoubi R; Ryan J; Biddle MS; Alshafie W; Fotouhi M; Bolivar SG; Ruiz Moleon V; Eckmann P; Worrall D; McDowell I; Southern K; Reintsch W; Durcan TM; Brown C; Bandrowski A; Virk H; Edwards AM; McPherson P; Laflamme C
    Elife; 2023 Nov; 12():. PubMed ID: 37995198
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison and critical analysis of robotized technology for monoclonal antibody high-throughput production.
    Chiarella P; Leuener M; Fasci C; de Marco A; Santini MP; Fazio VM; Sawyer AM
    Biotechnol Prog; 2011; 27(2):571-6. PubMed ID: 21425250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Covalent inactivation of factor VIII antibodies from hemophilia A patients by an electrophilic FVIII Analog.
    Planque S; Escobar MA; Smith KC; Taguchi H; Nishiyama Y; Donnachie E; Pratt KP; Paul S
    J Biol Chem; 2008 May; 283(18):11876-86. PubMed ID: 18337255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and evaluation of a new ELISA for the detection and quantification of antierythropoietin antibodies in human sera.
    Hoesel W; Gross J; Moller R; Kanne B; Wessner A; Müller G; Müller A; Gromnica-Ihle E; Fromme M; Bischoff S; Haselbeck A
    J Immunol Methods; 2004 Nov; 294(1-2):101-10. PubMed ID: 15604020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcytosis-blocking abs elicited by an oligomeric immunogen based on the membrane proximal region of HIV-1 gp41 target non-neutralizing epitopes.
    Matoba N; Griffin TA; Mittman M; Doran JD; Alfsen A; Montefiori DC; Hanson CV; Bomsel M; Mor TS
    Curr HIV Res; 2008 May; 6(3):218-29. PubMed ID: 18473785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives.
    Parray HA; Shukla S; Samal S; Shrivastava T; Ahmed S; Sharma C; Kumar R
    Int Immunopharmacol; 2020 Aug; 85():106639. PubMed ID: 32473573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones.
    Smith SA; de Alwis AR; Kose N; Jadi RS; de Silva AM; Crowe JE
    J Virol; 2014 Nov; 88(21):12233-41. PubMed ID: 25100837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation of a novel monoclonal antibody against inflammatory biomarker S100A8 using hybridoma technology.
    Kim JP; Yun H; Kim EJ; Kim YG; Lee CS; Ko BJ; Kim BG; Jeong HJ
    Biotechnol Lett; 2023 Jun; 45(5-6):589-600. PubMed ID: 36971774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiphospholipid antibodies: basic immunology and assays.
    Schultz DR
    Semin Arthritis Rheum; 1997 Apr; 26(5):724-39. PubMed ID: 9144849
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Scalable high throughput selection from phage-displayed synthetic antibody libraries.
    Miersch S; Li Z; Hanna R; McLaughlin ME; Hornsby M; Matsuguchi T; Paduch M; Sääf A; Wells J; Koide S; Kossiakoff A; Sidhu SS
    J Vis Exp; 2015 Jan; (95):51492. PubMed ID: 25651360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibodies: From novel repertoires to defining and refining the structure of biologically important targets.
    Conroy PJ; Law RH; Caradoc-Davies TT; Whisstock JC
    Methods; 2017 Mar; 116():12-22. PubMed ID: 28088364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.